1510820-22-0 Usage
Description
Ezetimibe Impurity, specifically 3-Dehydroxy Ezetimibe Open Ring Impurity, is an impurity found in the synthesis process of 3-Dehydroxy Ezetimibe. Ezetimibe Impurity is a derivative of Ezetimibe (E975000), which is an antihyperlipoproteinemic agent and a cholesterol absorption inhibitor. The presence of this impurity can affect the quality and efficacy of the final product, making it an important consideration in the manufacturing process.
Uses
Used in Pharmaceutical Industry:
Ezetimibe Impurity is used as a quality control measure for [application reason] in the synthesis of 3-Dehydroxy Ezetimibe, a derivative of Ezetimibe (E975000). This impurity is crucial for ensuring the purity and effectiveness of the final product, which is an antihyperlipoproteinemic agent and a cholesterol absorption inhibitor.
Used in Research and Development:
Ezetimibe Impurity is used as a research compound for [application reason] in the development of new drugs and therapies related to cholesterol absorption and hyperlipoproteinemia. Understanding the properties and effects of this impurity can contribute to the advancement of medical treatments for these conditions.
Used in Quality Assurance:
Ezetimibe Impurity is used as a reference material for [application reason] in the quality assurance processes of pharmaceutical manufacturers. This impurity can be used to set standards and benchmarks for the purity and quality of Ezetimibe and its derivatives, ensuring that the final products meet the required specifications and safety standards.
Check Digit Verification of cas no
The CAS Registry Mumber 1510820-22-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,1,0,8,2 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1510820-22:
(9*1)+(8*5)+(7*1)+(6*0)+(5*8)+(4*2)+(3*0)+(2*2)+(1*2)=110
110 % 10 = 0
So 1510820-22-0 is a valid CAS Registry Number.
1510820-22-0Relevant articles and documents
First synthesis of N-(4-fluorophenyl)-5-(4-fluorophenyl)-2(4- hydroxybenzyl)pentanamide, a new potential cholesterol absorption inhibitor
Guillon,Stiebing,Robba
, p. 25 - 29 (2007/10/03)
The first synthesis of N-(4-fluorophenyl)-5-(4-fluorophenyl)-2-(4- hydroxybenzyl)pentanamide and a new synthesis of 1-(4-fluorophenyl)-3-[(4- fluorophenyl)propyl]-4-(4-hydroxyphenyl)-2-azetidinone starting from 4- fluorobenzaldehyde are described. This new amide could represent a potential new cholesterol absorption inhibitor.
